发明授权
US07939662B2 Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
失效
无定形齐拉西酮盐酸盐（5- [2- [4-（1,2-苯并异噻唑-3-基）-1-哌嗪基]乙基] -6-氯-1,3-二氢-2H-吲哚-2-酮盐酸盐） 并进行生产
![Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same](/docs/US/2011-05-10/US07939662B2/abs.jpg.600x600.jpg)
- 专利标题： Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same
- 专利标题（中）： 无定形齐拉西酮盐酸盐（5- [2- [4-（1,2-苯并异噻唑-3-基）-1-哌嗪基]乙基] -6-氯-1,3-二氢-2H-吲哚-2-酮盐酸盐） 并进行生产
-
申请号： US11987926申请日： 2007-12-06
-
公开(公告)号： US07939662B2公开(公告)日： 2011-05-10
- 发明人: Carlos Zetina-Rocha , Allan W. Rey , Matthew A. Buck , Lotfi Derdour , Stephen E. Horne , Keshava K. S. Murthy
- 申请人： Carlos Zetina-Rocha , Allan W. Rey , Matthew A. Buck , Lotfi Derdour , Stephen E. Horne , Keshava K. S. Murthy
- 申请人地址： CA Branford
- 专利权人： Apotex Pharmachem Inc.
- 当前专利权人： Apotex Pharmachem Inc.
- 当前专利权人地址： CA Branford
- 优先权： CA2467538 20040514
- 主分类号： C07D417/00
- IPC分类号： C07D417/00
![Amorphous ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and processes to produce the same](/abs-image/US/2011/05/10/US07939662B2/abs.jpg.150x150.jpg)
摘要：
The present invention relates to a new and useful amorphous form of ziprasidone hydrochloride (5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one hydrochloride) and preparations thereof.
公开/授权文献
信息查询
